Skip to content

A clinical trial to compare the effects of giving lignocaine by intravenous or nebulization to reduce the pressor responses during endotracheal intubation and laryngoscopy.

Comparison of efficacy of nebulized lignocaine with intravenous lignocaine for attenuation of pressor response to laryngoscopy and intubation.

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040821
Enrollment
100
Registered
2022-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Intravenous 1.5mg/kg lignocaine bolus and nebulized lignocaine-2% for 20 minutes.: Comparison of efficacy of nebulized lignocaine 2% for 20minutes with intravenous lignocaine 1.5mg/kg b

Sponsors

Government of Gujarat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2 patients posted for surgery under general anaesthesia requiring endotracheal intubation.

Exclusion criteria

Exclusion criteria: Patients with pre existing hypertension, Patients with known allergy to the study drug or contraindication to any of the administered drugs, Patients with anticipated difficult airway, Patients who refused or inability to understand the procedure. 5. Patients who are smokers 6. Patients with History of respiratory distress 7. Patients with gastroesophageal reflux,Neurological ,cardiovascular,respiratory ,hepatic or renal dise

Design outcomes

Primary

MeasureTime frame
Evaluation of efficacy of the NL as compared to IVL in suppressing pressor response to laryngoscopy and intubation Timepoint: Starting of nebulized lignocaine/Intravenous lignocaine to 20th minute after endotracheal intubation.

Secondary

MeasureTime frame
Evaluation of efficacy of the 2% lignocaine nebulization for 20minutes as compared to 1.5mg/kg intravenous lignocaine bolus in suppression of arrhythmias/any other complications if any during laryngoscopy and intubation. Timepoint: Preoperatively before induction starting of 2% nebulized lignocaine/1.5mg/kg Intravenous lignocaine upto 20 minutes after endotracheal intubation.

Countries

India

Contacts

Public ContactDr Smita R Engineer

B.J medical College, Civil Hospital, Ahmedabad

seng_90@yahoo.com9825504948

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026